Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Nature Reviews. Cancer
|
October 17, 2008
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J Harper, David O Bates
Future Oncology (London, England)
|
March 25, 2006
Therapeutic potential of inhibitory VEGF splice variants
David O Bates, Steven J Harper
Kidney International. Supplement
|
April 16, 2003
Endothelial permeability in uremia
Steven J Harper, David O Bates
Journal of the American Society of Nephrology : JASN
|
November 13, 2010
Glomerular filtration barrier and molecular segregation: guilty as charged?
Steven J Harper, David O Bates
Cancer Letters
|
October 10, 2006
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm
Michael R Ladomery, Steven J Harper, David O Bates
Cell Biochemistry and Biophysics
|
October 2, 2007
A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus
Rachel M Perrin, Steven J Harper, David O Bates
Future Oncology (London, England)
|
June 13, 2009
Therapeutic potential of manipulating VEGF splice isoforms in oncology
Emma S Rennel, Steven J Harper, David O Bates
Molecular Vision
|
June 19, 2014
TNF-α-induced ICAM-1 expression and monocyte adhesion in human RPE cells is mediated in part through autocrine VEGF stimulation
Peeradech Thichanpiang, Steven J Harper, Kanokpan Wongprasert, et al.
Kidney International
|
March 29, 2002
Human uremic plasma increases microvascular permeability to water and proteins in vivo
Steven J Harper, Charles R V Tomson, David O Bates
Current Opinion in Nephrology and Hypertension
|
April 15, 2009
New aspects of glomerular filtration barrier structure and function: five layers (at least) not three
Andrew H J Salmon, Christopher R Neal, Steven J Harper
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Nature Reviews. Cancer
|
October 17, 2008
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J Harper, David O Bates
Future Oncology (London, England)
|
March 25, 2006
Therapeutic potential of inhibitory VEGF splice variants
David O Bates, Steven J Harper
Kidney International. Supplement
|
April 16, 2003
Endothelial permeability in uremia
Steven J Harper, David O Bates
Journal of the American Society of Nephrology : JASN
|
November 13, 2010
Glomerular filtration barrier and molecular segregation: guilty as charged?
Steven J Harper, David O Bates
Cancer Letters
|
October 10, 2006
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm
Michael R Ladomery, Steven J Harper, David O Bates
Cell Biochemistry and Biophysics
|
October 2, 2007
A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus
Rachel M Perrin, Steven J Harper, David O Bates
Future Oncology (London, England)
|
June 13, 2009
Therapeutic potential of manipulating VEGF splice isoforms in oncology
Emma S Rennel, Steven J Harper, David O Bates
Molecular Vision
|
June 19, 2014
TNF-α-induced ICAM-1 expression and monocyte adhesion in human RPE cells is mediated in part through autocrine VEGF stimulation
Peeradech Thichanpiang, Steven J Harper, Kanokpan Wongprasert, et al.
Kidney International
|
March 29, 2002
Human uremic plasma increases microvascular permeability to water and proteins in vivo
Steven J Harper, Charles R V Tomson, David O Bates
Current Opinion in Nephrology and Hypertension
|
April 15, 2009
New aspects of glomerular filtration barrier structure and function: five layers (at least) not three
Andrew H J Salmon, Christopher R Neal, Steven J Harper
Page
of 7